Procizumab (PCZ; AK1967) in Critical Cardiovascular Care — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(16 sites)
Belgium
Heart Center Aalst, AZORG, Aalst University Hospital Saint Pierre, Brussels Czechia
University Hospital and Medical Faculty of Pilsen, Pilsen Charles University Motol University Hospital, Prague General University Hospital in Prague - FVN, Prague Institute of Clinical and Experimental Medicine - IKEM, Prague France
University Hospital Avicenne AP-HP, Bobigny University Hospital Lille - Institut Cœur Poumon, Lille University Hospital - Dupuytren Limoges, Limoges Regional University Hospital Nancy - Hopitaux de Brabois, Nancy Lariboisière Hospital AP-HP, Paris Netherlands
Radboud University Medical Center, Nijmegen Poland
Uniersytecki Szpital Kliniczny w Białystoku, Bialystok Górnośląskie Centrum Medyczne w Katowicach / Śląski Uniwersytet Medyczny w Katowicach, Katowice Clinical University Hospital Poznań, Poznan J. Mikulicz Radecki Clinical University Hospital Wrocław, Wroclaw Last updated January 2026